218 related articles for article (PubMed ID: 18651727)
1. Synthesis of GABAA receptor agonists and evaluation of their alpha-subunit selectivity and orientation in the GABA binding site.
Jansen M; Rabe H; Strehle A; Dieler S; Debus F; Dannhardt G; Akabas MH; Lüddens H
J Med Chem; 2008 Aug; 51(15):4430-48. PubMed ID: 18651727
[TBL] [Abstract][Full Text] [Related]
2. Activity of novel 4-PIOL analogues at human alpha 1 beta 2 gamma 2S GABA(A) receptors--correlation with hydrophobicity.
Mortensen M; Frølund B; Jørgensen AT; Liljefors T; Krogsgaard-Larsen P; Ebert B
Eur J Pharmacol; 2002 Sep; 451(2):125-32. PubMed ID: 12231381
[TBL] [Abstract][Full Text] [Related]
3. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
[TBL] [Abstract][Full Text] [Related]
4. Effects of GABA(A) receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions.
Hansen SL; Ebert B; Fjalland B; Kristiansen U
Br J Pharmacol; 2001 Jun; 133(4):539-49. PubMed ID: 11399671
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding.
Gielen MC; Lumb MJ; Smart TG
J Neurosci; 2012 Apr; 32(17):5707-15. PubMed ID: 22539833
[TBL] [Abstract][Full Text] [Related]
6. Novel class of potent 4-arylalkyl substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
Frølund B; Jørgensen AT; Tagmose L; Stensbøl TB; Vestergaard HT; Engblom C; Kristiansen U; Sanchez C; Krogsgaard-Larsen P; Liljefors T
J Med Chem; 2002 Jun; 45(12):2454-68. PubMed ID: 12036354
[TBL] [Abstract][Full Text] [Related]
7. Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.
Ebert B; Wafford KA; Whiting PJ; Krogsgaard-Larsen P; Kemp JA
Mol Pharmacol; 1994 Nov; 46(5):957-63. PubMed ID: 7969086
[TBL] [Abstract][Full Text] [Related]
8. Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human gamma-aminobutyric acid type A receptors.
Ebert B; Thompson SA; Saounatsou K; McKernan R; Krogsgaard-Larsen P; Wafford KA
Mol Pharmacol; 1997 Dec; 52(6):1150-6. PubMed ID: 9396785
[TBL] [Abstract][Full Text] [Related]
9. 4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists: synthesis, pharmacology, and structure-activity relationships.
Frølund B; Jensen LS; Storustovu SI; Stensbøl TB; Ebert B; Kehler J; Krogsgaard-Larsen P; Liljefors T
J Med Chem; 2007 Apr; 50(8):1988-92. PubMed ID: 17375905
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological subtypes of the gamma-aminobutyric acidA receptors defined by a gamma-aminobutyric acid analogue 4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol and allosteric coupling: characterization using subunit-specific antibodies.
Huh KH; Delorey TM; Endo S; Olsen RW
Mol Pharmacol; 1995 Oct; 48(4):666-75. PubMed ID: 7476892
[TBL] [Abstract][Full Text] [Related]
11. A transmembrane amino acid in the GABAA receptor β2 subunit critical for the actions of alcohols and anesthetics.
McCracken ML; Borghese CM; Trudell JR; Harris RA
J Pharmacol Exp Ther; 2010 Dec; 335(3):600-6. PubMed ID: 20826568
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of structural changes at the GABA(A) receptor transmitter binding site.
Akk G; Li P; Bracamontes J; Wang M; Steinbach JH
Br J Pharmacol; 2011 Feb; 162(4):840-50. PubMed ID: 20958292
[TBL] [Abstract][Full Text] [Related]
13. On high- and low-affinity agonist sites in GABAA receptors.
Baur R; Sigel E
J Neurochem; 2003 Oct; 87(2):325-32. PubMed ID: 14511110
[TBL] [Abstract][Full Text] [Related]
14. A (beta)-strand in the (gamma)2 subunit lines the benzodiazepine binding site of the GABA A receptor: structural rearrangements detected during channel gating.
Teissére JA; Czajkowski C
J Neurosci; 2001 Jul; 21(14):4977-86. PubMed ID: 11438573
[TBL] [Abstract][Full Text] [Related]
15. Novel 4-(piperidin-4-yl)-1-hydroxypyrazoles as gamma-aminobutyric acid(A) receptor ligands: synthesis, pharmacology, and structure-activity relationships.
Møller HA; Sander T; Kristensen JL; Nielsen B; Krall J; Bergmann ML; Christiansen B; Balle T; Jensen AA; Frølund B
J Med Chem; 2010 Apr; 53(8):3417-21. PubMed ID: 20355712
[TBL] [Abstract][Full Text] [Related]
16. Individually monitoring ligand-induced changes in the structure of the GABAA receptor at benzodiazepine binding site and non-binding-site interfaces.
Sharkey LM; Czajkowski C
Mol Pharmacol; 2008 Jul; 74(1):203-12. PubMed ID: 18424553
[TBL] [Abstract][Full Text] [Related]
17. A novel class of potent 3-isoxazolol GABA(A) antagonists: design, synthesis, and pharmacology.
Frølund B; Tagmose L; Liljefors T; Stensbøl TB; Engblom C; Kristiansen U; Krogsgaard-Larsen P
J Med Chem; 2000 Dec; 43(26):4930-3. PubMed ID: 11150163
[No Abstract] [Full Text] [Related]
18. GABA-induced intersubunit conformational movement in the GABAA receptor alpha 1M1-beta 2M3 transmembrane subunit interface: experimental basis for homology modeling of an intravenous anesthetic binding site.
Bali M; Jansen M; Akabas MH
J Neurosci; 2009 Mar; 29(10):3083-92. PubMed ID: 19279245
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of a new series of 4-alkylated 3-isoxazolol GABA A antagonists.
Frølund B; Tagmose L; Jørgensen AT; Kristiansen U; Stensbøl TB; Liljefors T; Krogsgaard-Larsen P
Eur J Med Chem; 2003 Apr; 38(4):447-9. PubMed ID: 12750034
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site.
Street LJ; Sternfeld F; Jelley RA; Reeve AJ; Carling RW; Moore KW; McKernan RM; Sohal B; Cook S; Pike A; Dawson GR; Bromidge FA; Wafford KA; Seabrook GR; Thompson SA; Marshall G; Pillai GV; Castro JL; Atack JR; MacLeod AM
J Med Chem; 2004 Jul; 47(14):3642-57. PubMed ID: 15214791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
